Inventor · disambiguated record
Ludwig Zorn
Also filed as: ZORN LUDWIG
35 granted patents·20 pending applications·159 citations·filing 1998–2022
96Inventor score
Top patents by PatentIndex Score
55 records- 0194US9284319B2Heterocyclyl aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Mar 15, 2016·28 cites·5 claims
- 0292US9320737B2Substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted Apr 26, 2016·27 cites·12 claims
- 0390US9730929B2Substituted aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Aug 15, 2017·25 cites·14 claims
- 0484US7148357B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesSCHERING AG·Filed 2003·Granted Dec 12, 2006·15 cites·3 claims
- 0583US7202260B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridonesSCHERING AG·Filed 2004·Granted Apr 10, 2007·11 cites·14 claims
- 0681US8263040B2Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their usePLATZEK JOHANNES·Filed 2007·Granted Sep 11, 2012·2 cites·31 claims
- 0781US7615565B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 10, 2009·3 cites·9 claims
- 0879US7618957B2Perfluoroalkyl-containing complexes, process for their production as well as their useBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 17, 2009·1 cites·6 claims
- 0979US6844336B24-fluoroalkyl-2h-benzopyrans with anti-estogenic activitySCHERING AG·Filed 2001·Granted Jan 18, 2005·14 cites·36 claims
- 1078US11304946B22-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonistsBAYER AG·Filed 2018·Granted Apr 19, 2022·2 cites·11 claims
- 1177US11040035B23-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamidesBayer Pharma AG·Filed 2017·Granted Jun 22, 2021·2 cites·9 claims
- 1275US9409889B2Amino-substituted imidazopyridazinesBayer Pharma AG·Filed 2013·Granted Aug 9, 2016·3 cites·9 claims
- 1374US9499547B2Amino-substituted imidazopyridazinesEIS KNUT·Filed 2012·Granted Nov 22, 2016·3 cites·16 claims
- 1473US11459312B2Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamidesBAYER AG·Filed 2018·Granted Oct 4, 2022·2 cites·12 claims
- 1573US9877954B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2017·Granted Jan 30, 2018·1 cites·15 claims
- 1673US6790842B111β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTSSCHERING AG·Filed 2000·Granted Sep 14, 2004·7 cites·15 claims
- 1771US9708311B2Benzimidazole derivatives as EP4 antagonistsBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·2 cites·10 claims
- 1870US9650340B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted May 16, 2017·1 cites·9 claims
- 1968US11524944B22-phenylpyrimidine-4-carboxamides as AHR inhibitorsBAYER AG·Filed 2018·Granted Dec 13, 2022·1 cites·11 claims
- 2066US11591311B23-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamidesBAYER AG·Filed 2018·Granted Feb 28, 2023·1 cites·8 claims
- 2163US7935827B2Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto estersBAYER SCHERING PHARMA AG·Filed 2008·Granted May 3, 2011·0 cites·9 claims
- 2262US2021024490A1Method for the preparation of the metabolites of (4s)- and (4r)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and the use thereofBayer Pharma AG·Filed 2020·Application pending·0 cites
- 2356US2007135489A1Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridonesHUTH ANDREAS·Filed 2007·Application pending·0 cites
- 2456US2009297454A1Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their UseSCHIRMER HEIKO·Filed 2009·Application pending·0 cites
- 2555US7626035B2Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto estersBAYER SCHERING PHARMA AG·Filed 2005·Granted Dec 1, 2009·0 cites·20 claims
- 2654US7262023B2Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereofBAYER SCHERING PHARMA AG·Filed 2003·Granted Aug 28, 2007·0 cites·10 claims
- 2754US2024174683A1Map4k1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 2853US2023212532A1P450 bm3 monooxygenase variants for c19-hydroxylation of steroidsBAYER AG·Filed 2021·Application pending·0 cites
- 2952US2004039019A1Selected anthranilaminde pyridinamides and their use as pharmaceutical agentsSCHERING AG·Filed 2003·Application pending·0 cites
- 3050US2011130371A1C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical preparations comprising the sameBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 3148US6780855B211β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTSSCHERING AG·Filed 1998·Granted Aug 24, 2004·8 cites·27 claims
- 3248US2023113037A1[1,2,4]triazolo[1,5-c]quinazolin-5-aminesBAYER AG·Filed 2020·Application pending·0 cites
- 3346US2018237414A1Method for the preparation of the metabolites of (4s)- and (4r)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and the use thereofBayer Pharma AG·Filed 2016·Application pending·0 cites
- 3445US9670161B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone groupBayer Pharma AG·Filed 2013·Granted Jun 6, 2017·0 cites·5 claims
- 3545US7517894B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesBAYER SCHERING PHARMA AG·Filed 2004·Granted Apr 14, 2009·0 cites·11 claims
- 3644US9708293B2N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone groupBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·0 cites·12 claims
- 3743US9783543B2AminoimidazopyridazinesBayer Pharma AG·Filed 2013·Granted Oct 10, 2017·0 cites·8 claims
- 3843US9745304B2Amidoimidazopyridazines as MKNK-1 kinase inhibitorsBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·0 cites·9 claims
- 3942US10130633B2CompoundsBayer Pharma AG·Filed 2014·Granted Nov 20, 2018·0 cites·17 claims
- 4042US9777004B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2013·Granted Oct 3, 2017·0 cites·9 claims
- 4142US2016052898A1Novel compoundsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4241US9643974B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·0 cites·9 claims
- 4340US2015080438A16,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicamentsBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 4439US10919862B2Fused imidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Feb 16, 2021·0 cites·25 claims
- 4539US2014288069A1Amino-substituted imidazopyridazines as mknk1 kinase inhibitorsEIS KNUT·Filed 2012·Application pending·0 cites
- 4636US9650361B2N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine groupBAYER PHARAM AG·Filed 2013·Granted May 16, 2017·0 cites·15 claims
- 4736US2013252890A16,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicamentsWINTERMANTEL TIM·Filed 2011·Application pending·0 cites
- 4836US2007020183A1Perfluoroalkyl-containing complexes, process for their production as well as their useSCHIRMER HEIKO·Filed 2006·Application pending·0 cites
- 4935US10214545B2Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disordersBayer Pharma AG·Filed 2015·Granted Feb 26, 2019·0 cites·21 claims
- 5034US2003187287A1Synthesis intermediate products for producing vitamin d derivativesFiled 2001·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ludwig Zorn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →